Retatrutide is currently in phase 3 clinical trials and has not yet been approved by the FDA
Subsequently, other drugs such as Novos Victoza (liraglutide, approved in 2010), AstraZenecas Bydureon (exenatide, 2012), GSKs Tanzeum (albiglutide, 2014), Lillys Trulicity (dulaglutide, 2014) and Novos Ozempic (semaglutide, 2017) and Rybelsus (oral semaglutide, 2019) were approved
Semaglutide, marketed by the company Novo Nordisk, is also a GLP-1 agonist
GLP-1 receptor agonists mechanism of action mimics the naturally occurring GLP-1 in the body, which results in improved blood sugar control
"Everything I used to eat makes me feel sick now," she said, frustrated
Female infertility: Causes